Epinex's Patent Granted for Revolutionary Diabetes Test (Marketwire via Yahoo! Finance)

2 March 2010, 4:30 am

TUSTIN, CA--(Marketwire - 03/02/10) - The United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1A Rapid Diabetes Monitoring Index Test . The patent (US7659107B2) is for the first ever rapid glycated albumin test and instrument, which could redefine the way diabetes is monitored for over 250 million diabetics worldwide. The G1A ...... Read More »

More Topics from "News"

• Sheriff's Patrol Log: Multiple suspects assault victims at Castroville business (The Salinas Californian)
• AE Linux Is Available on Cinnamon Bay SBC Featuring Intel(R) Atom(TM) Processors (Marketwire)
• AE Linux Is Available on Cinnamon Bay SBC Featuring Intel(R) Atom(TM) Processors (Marketwire via Yahoo! Finance)
• Epinex's Patent Granted for Revolutionary Diabetes Test (Marketwire)
• FEI # 1002.147558 NOTICE OF (Patterson Irrigator)
• Things to do in Tustin: Business tips; Sheriff Candidates Forum (Tustin News)
• OUTDOORS: Weekly fishing report, Feb. 25 (North County Times)
• Biz expert on Toyota: Consumer trust is fragile (Orange County Register)
• School district files lawsuit against Tustin (Orange County Register)